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In recent years, long noncoding RNAs (lncRNAs) have emerged as an important class of regulators of gene
expression. lncRNAs exhibit several distinctive features that confer unique regulatory functions, including
exquisite cell- and tissue-specific expression and the capacity to transduce higher-order spatial information.
Here we review evidence showing that lncRNAs exert critical functions in adult tissue stem cells, including
skin, brain, and muscle, as well as in developmental patterning and pluripotency. We highlight new ap-
proaches for ascribing lncRNA functions and discuss mammalian dosage compensation as a classic
example of an lncRNA network coupled to stem cell differentiation.Introduction
Efforts to understand how tissues are patterned during develop-
ment andmaintained by stem cells throughout life have tradition-
ally focused on the protein-coding genome. Over the past
decade, however, our understanding of the noncoding genome
and its impact on cell fate has dramatically expanded. Contrary
to previous notions of genome organization and function, the
identification of thousands of long and short noncoding RNAs
(ncRNAs) has revealed that much of the genome is in fact tran-
scribed. Long noncoding RNAs (lncRNAs) are operationally
defined as transcripts of greater than 200 nucleotides that func-
tion by means other than coding for proteins; lncRNAs are typi-
cally transcribed byRNApolymerase II and are frequently spliced
and polyadenylated (reviewed by Rinn and Chang, 2012). As a
class, lncRNAs tend to be expressed at lower levels and are pre-
dominantly localized in the nucleus, in contrast to messenger
RNAs, which are abundant and enriched in the cytoplasm
(Derrien et al., 2012). Notwithstanding these generalizations,
lncRNAs exhibit a wide range of expression levels and distinct
cytotopic localizations, reflecting a large anddiverse class of reg-
ulators (reviewed by Batista and Chang, 2013). Several well-
studied examples of lncRNAs suggest that they can operate
through distinct modes, including as signals, scaffolds for pro-
tein-protein interactions, molecular decoys, and guides to target
elements in the genome or transcriptome (Wang and Chang,
2011). The discovery of novel lncRNAs has historically outpaced
their functional annotation; however, efforts to more specifically
ascribe function to either previously identified or novel lncRNAs
have increased in recent years. Stem cells offer an attractive sys-
tem for studying lncRNA function since previous findings have
suggested that lncRNA expression is more cell-type-specific
than mRNA expression (Cabili et al., 2011), leading to the possi-
bility that lncRNAs may be key regulators of cell fate.
Here we review recent developments that illuminate the roles
of lncRNAs in stem cell biology. We explore efforts to charac-
terize the functions of lncRNAs in the development and
patterning of several somatic tissues, including skin, brain, and
musculature. Additionally, we examine how lncRNAs contribute
to the pluripotent state and can be used to assess reprogram-
ming status.752 Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc.LncRNAs in Adult Tissue Stem Cells
Skin: An Ideal Model
Studying the biology of tissues at the molecular level necessi-
tates robust model systems. While there are few systems that
are suitable for detailed molecular characterization, well-devel-
oped human models exist for the skin based on ex vivo tissue
regeneration that can also be grafted in vivo (Sen et al., 2010;
Truong et al., 2006). Such models provide cellular material for
molecular and biochemical studies that would be otherwise
inaccessible and offer a system for testing the function of
lncRNAs. Surveying the pattern of gene expression during
epidermal differentiation, Khavari and colleagues discovered
two key lncRNAs, ANCR and TINCR, that are expressed in
epidermal stem cells and their terminally differentiated progeny,
respectively (Kretz et al., 2012, 2013) (Figure 1). Antidifferentia-
tion noncoding RNA (ANCR) provides a prime example of an
lncRNA that controls the differentiation state of a somatic stem
cell (Kretz et al., 2012). Specifically, ANCR depletion results in
ectopic differentiation of epidermal stem cells, implying that
ANCR’s role is to suppress the differentiation pathway in the
epidermis and maintain the stem cell compartment.
While ANCR appears to inhibit differentiation, a different
lncRNA termed terminal differentiation-induced noncoding
RNA (TINCR) promotes epidermal differentiation (Kretz et al.,
2013). TINCR is kept at very low levels in epidermal stem cells,
but it is dramatically induced upon differentiation. Mechanistic
studies of TINCR revealed that TINCR is a cytoplasmic lncRNA
that interacts with the RNA-binding protein (RBP) STAU1 and
converts STAU1 into an mRNA stability factor (Figure 1).
Together, TINCR and STAU1 bind to and functionally stabilize
mRNAs that encode structural and regulatory proteins critical
for terminally differentiated keratinocytes. Additionally, TINCR
expression is downregulated in human squamous cell carci-
noma, providing evidence that lncRNAs can functionally regulate
healthy and disease tissues.
The development of two techniques made these insights
possible: (1) RNA interactome analysis (RIA), which allows the
retrieval and unbiased discovery of RNAs interacting with an
lncRNA of interest, and (2) protein microarray hybridization,
which allows rapid discovery of direct RBP partners of an
Figure 1. lncRNAs Control Differentiation
and Self-Renewal
Several lncRNAs that regulate specific somatic
tissue stem cell renewal or differentiation and their
protein partners are depicted. Some lncRNAs
maintain the stem cell state, while others promote
a differentiation program. Their functions are often
facilitated by protein partners that impart the
ability to activate or repress gene expression or
posttranscriptionally regulate other RNAs.
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were identified from large-scale expression profiling studies,
suggesting that many additional lncRNAs may be identified
and characterized using this system. Indeed, the differentiation
of the skin is a multistep and highly regulated process that could
benefit from the diverse set of lncRNAs hiding in the genome.
The development of techniques such as RIA and the implemen-
tation of protein microarrays facilitated the functional character-
ization of TINCR but are applicable to uncoveringmechanisms of
other lncRNAs. Within the skin, the regulated and sequential
expression of lncRNAs is clearly essential for their function;
thus, understanding what controls the spatiotemporal expres-
sion of lncRNAs, such as ANCR and TINCR, should be the focus
of future studies.
Regulation in the Brain
Transcription and alternative splicing in the brain appear to be
the most complex among all organs (Mehler and Mattick,
2007; Mercer et al., 2008). An early example of lncRNAs control-
ling neural cell fates involves the Evf2 lncRNA and the Dlx5/6
genomic locus (Bond et al., 2009). Evf2 is transcribed antisense
to Dlx6, which encodes a transcription factor, and is located
immediately downstream of the Dlx5 genomic locus. The act of
transcribing Evf2 can control the levels of Dlx6 in cis, and after
disengaging the polymerase, Evf2 acts in trans to modulate the
methylation of the Dlx5/6 enhancer and transcription of Dlx5.
Therefore, by regulating the cellular levels of the Dlx5 and Dlx6
transcription factors, Efv2 controls GABAergic interneuron activ-
ity (Berghoff et al., 2013; Bond et al., 2009). A different study
characterizing another lncRNA important for neural differentia-
tion found that an enhancer region of the gene encoding the
Neurogenin 1 transcription factor was transcribed and produced
an lncRNA that positively regulated Neurogenin 1 expression
(Onoguchi et al., 2012). These few examples begin to build the
case that lncRNAs play an important role in neural biology.
The starting point of many lncRNA studies is unbiased gene
expression analysis, which can reveal novel lncRNAs and theirCell Stem Ceexpression pattern in a developmental
context. Recent large-scale efforts have
employed next generation sequencing
(‘‘-seq’’) technologies, from RNA-seq to
chromatin immunoprecipitation (ChIP-
seq), to identify transcripts and define
their genomic positions (reviewed by
Rinn and Chang, 2012). In the mouse
brain, Lim and colleagues isolated three
separate regions, subventricular zone
(SVZ), olfactory bulb (OB), and the den-
tate gyrus (DG), and subjected thesesamples to short-read RNA-seq and ChIP-seq (Ramos et al.,
2013). Over 3,600 novel lncRNAs were identified, and clustering
of the lncRNAs and mRNAs by their expression patterns re-
vealed that the lncRNAs were more tissue specific than mRNAs,
consistent with previous reports (Cabili et al., 2011). Application
of CaptureSeq, a technique that circumvents some drawbacks
of short-read sequencing (Mercer et al., 2012), to further charac-
terize the transcriptome of adult SVC tissue doubled the number
(to 7,000) of novel lncRNAs identified. To functionally validate
the cataloging effort, two lncRNAs were identified by selecting
loci marked by H3K4me3, which is associated with expressed
genes, in NPC-SVC cells. This search identified Six3os and
Dlx1as for further testing. Notably, Six3os has been previously
reported to control retinal development (Rapicavoli et al.,
2011). To characterize the neural role of Six3os and Dlx1as,
SVZ neural progenitor cells were challenged in a 7-day differen-
tiation assay with short hairpin RNAs targeting the two lncRNAs
or control shRNAs. Depletion of Six3os lncRNA leads to fewer
Tuj1 (neuron marker)- and OLIG2 (oligodentrocyte marker)-pos-
itive cells, whereas depletion of Dlx1as specifically affected the
number of Tuj1-positive cells (Figure 1). While the molecular
mechanisms of these lncRNAs were not explored, Six3os has
been shown to physically interact with Ezh2, a component of
the Polycomb repressive complex 2 (PRC2), to repress specific
genes in retinal cells (Rapicavoli et al., 2011). These examples
illustrate that mapping spatiotemporal patterns of lncRNAs can
highlight functional transcripts. Larger-scale validation efforts
will be required to fully realize the extent of lncRNA regulation
in the different regions of the brain.
A complementary approach identifies potential lncRNA regu-
lators based on their loss-of-function phenotypes in large-scale
depletion studies (Guttman et al., 2011; Lin et al., 2014). Rana
and colleagues targeted 1,280 mouse lncRNAs and identified
20 lncRNAs that were required for the maintenance of mouse
embryonic stem cell (mESC) pluripotency. One lncRNA, named
TUNA, was previously identified as megamind in zebrafish.ll 14, June 5, 2014 ª2014 Elsevier Inc. 753
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velopment and impaired locomotor response (Ulitsky et al.,
2011; Lin et al., 2014). TUNA is highly conserved in human and
fish, is required for the maintenance of pluripotency, and is
also expressed in the brain, spinal cord, and eyes in adult tis-
sues. Indeed, TUNA expression was increased when mESCs
differentiated toward the neural lineages, and TUNAdepletion in-
hibited neural differentiation of ESCs (Figure 1). Purifying pro-
teins that associate with in vitro-transcribed TUNA identified
hnRNP-K, Nucleolin (NCL), and PTBP1 as interaction partners.
Importantly, depletion of several of these proteins phenocopied
TUNA depletion (Lin et al., 2014). An important caveat to
consider is that while the candidate approach characterized
TUNA, Six3os, and Dlx1as lncRNAs as successful validation of
genome-wide screens, such approaches leave the function of
thousands of other transcripts, many of which may play impor-
tant roles, unaddressed.
Many lncRNAs have been implicated in the regulation of chro-
matin states (Rinn and Chang, 2012), but direct evidence for their
association has only recently been possible through the develop-
ment chromatin isolation by RNA purification (ChIRP; and others
methods discussed below) (Chu et al., 2011). ChIRP uses DNA
capture probes to retrieve a specific lncRNA with its associated
genomic DNA targets, and together with deep sequencing can
generate a genome-widemapof lncRNA-chromatin interactions.
Careful optimization of in vivo crosslinking, both of the chemical
crosslinking agent and duration, and selection of proper oligonu-
cleotide probes are important to obtain reliable measurement.
This process often includes multiple but distinct DNA capture
probe sets, probes targeting irrelevant RNAs as negative con-
trols, and positive control regions to assay during pilot experi-
ments (Chu et al., 2011). Successful implementation of ChIRP
has revealed the lncRNA TUNA occupies promoter regions of
Nanog,Sox2, and Fgf4, genes that are important for pluripotency
and neural lineage commitment (Lin et al., 2014). Togetherwith its
protein partners and its chromatin localization, TUNA may
regulate gene expression at both the transcriptional and post-
transcriptional level. Thus, TUNA represents an lncRNA that is
important for at least two cell states (ESCpluripotency and neural
differentiation) andprobably operates throughmultiplemolecular
mechanisms. This example highlights the concept that a single
lncRNA can, under different cellular context and protein partners,
function to control multiple molecular pathways.
lncRNAs and Muscle
LncRNAs also control development of mesodermal tissues and
have similarly benefited from large-scale sequencing efforts to
identify functionally important transcripts. One example of a
heart-specific lncRNA named Braveheart was first functionally
characterized as a key factor involved in cardiac lineage commit-
ment because its depletion resulted in a severe reduction in the
number of spontaneous beating cardiomyocytes formed during
embryoid body differentiation (Klattenhoff et al., 2013) (Figure 1).
Further characterization of Braveheart found that it interacts with
Suz12, a subunit of PRC2, and acts in trans to regulate heart-
specific differentiation genes such as MesP1. The regulation of
master drivers of cardiac differentiation, such as MesP1 by
Braveheart, offers new tools toward the goal of achieving highly
efficient and reproducible in vitro reprograming (Burridge et al.,
2012). Producing cardiomyocytes from induced pluripotency754 Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc.stem cells (iPSCs) or directly from other differentiated cell types
may benefit from engineering specific lncRNA expression during
in vitro production.
While small interfering RNA (siRNA) knockdown of lncRNAs
(used in most of the discussed work) often provides a great
deal of insight into function, off-target effects and incomplete
depletion must always been considered. As with protein-coding
genes, knockout (KO) strategies offer potential remedies to
these siRNA-related issues, but the specific strategy employed
is critical (discussed below: Developmental Patterning by
lncRNAs). Utilizing this concept, Herrmann and colleagues in-
serted a premature polyadenylation (polyA) signal into the
lncRNA Fendrr’s locus to promote depletion of the full-length
Fendrr RNA (Grote et al., 2013). Initial characterization of Fendrr
found it expressed in the caudal end of the lateral plate meso-
derm (LPM), which develops into the structures like the heart
and body wall. Fendrr KO resulted in embryonic lethality at em-
bryonic day 13.75, abdominal wall defects, and pooling of blood
in the right atrium. By partnering with both activating (mixed-line-
age Leukemia [MLL], WDR5) and silencing (PRC2) chromatin
complexes, Fendrr was proposed to modulate the epigenetic
landscape during development (Figure 1). More recently ChIRP
was used to show that Fendrr physically associates with the pro-
moters of FoxF1 and Pitx2 mRNAs, two genes repressed by
Fendrr (Grote and Herrmann, 2013; Grote et al., 2013). Fendrr
therefore represents a dual-function lncRNA that may control
both positive and negative chromatin modifying complexes to
guide development.
Long RNAs Controlling Small RNAs
The differentiation of a myoblast progenitor cell (MB) to a fully
differentiated muscle cell is a highly regulated process that relies
on Ying Yang 1 (YY1), a multifunctioning transcription factor
(Deng et al., 2010; Lu et al., 2012). Examination of YY1’s chro-
matin binding pattern in MBs revealed that it bound the promoter
of many ncRNA loci, and these target noncoding genes were
named YY1-associated muscle lncRNAs (Yam) (Lu et al.,
2013). Characterization of one of these lncRNAs, Yam1, identi-
fied it as a key regulator of myogenesis, as it was able to repress
key muscle differentiation genes including myogenin, Tnni2, and
a-actin, (Figure 1). Furthermore, Yam1 increased levels of
microRNA-715 (miR-715), which targets Wnt7b, a protein that
normally promotes muscle differentiation (Lu et al., 2013).
Yam1 thus provides evidence that inmuscle lncRNAs canmodu-
late the levels of both mRNAs and other ncRNAs, such as
miRNAs, providing additional network control to cells.
The regulation of miRNA networks reveals an additional mech-
anism through which lncRNAs exert control. Recently, multiple
lncRNAs have been shown to act as competing endogenous
RNAs (ceRNAs), where the lncRNAs are proposed to bind to and
compete miRNAs away from cognate mRNA targets (Tay et al.,
2014). Pseudogene lncRNAs are prime candidates for the ceRNA
mechanism because they may share multiple miRNA binding
sites, allowing more effective competition with cognate mRNAs.
The ceRNAhypothesis requires that ceRNAsare expressedhighly
enough and have sufficient numbers of miRNA binding sites to
substantially affect the pool of cellular miRNAs. Recent work
exploring the dynamics of miRNA-regulated gene repression has
shown that it is highly susceptible to thresholds. In certain
contexts, small concentration changes of miRNA-mRNA or
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sion network (Bosia et al., 2013; Mukherji et al., 2011). Moreover,
one example of a ceRNA, linc-MD1, has been previously show
to regulate muscle differentiation through its ability to sponge
miR-133 and miR-135 away from the mRNAs MAML1 and
MEF2C (Cesana et al., 2011). These two mRNAs are important
transcriptional activators of the muscle differentiation program.
Linc-MD1 itself contains an miR-133b, which represses muscle
differentiation when processed. Recent molecular characteriza-
tion of this network revealed the RBP HuR bound to linc-MD1
and the levels of linc-MD1 positively correlated with HuR protein
abundance (Legnini et al., 2014) (Figure 1). HuR controlled the
fate of linc-MD1, as cellular depletion of HuR favored the process-
ing of linc-MD1 into miR-133b, tipping the balance in favor of the
miRNA over the ceRNA. HuR has known roles in myogenesis
and its interaction with linc-MD1 fine-tunes the levels of miRNAs
important in the muscle differentiation program. Together, these
studies explore lncRNA functions in muscle tissue and help to
expand thepossiblemodesof lncRNA functionswithin the already
complex system of miRNA-mediated gene regulation.
Developmental Patterning by lncRNAs
lncRNAs also orchestrate the patterning of cells into tissues and
organs during development. HOTAIR lncRNA was one of the
first characterized lncRNAs that acts at distance (in trans) to
modulate Hox gene expression (Rinn et al., 2007). HOTAIR is a
repressive lncRNA and serves a scaffold between two distinct
chromatin modification complexes (Rinn et al., 2007; Tsai
et al., 2010). Other Hox-encoded lncRNAs such as HOTTIP,
Mistral, and HOTAIRm1 were shown to regulate different mem-
bers of HoxA genes (Bertani et al., 2011; Wang et al., 2011;
Zhang et al., 2009). For example, HOTTIP is expressed in distal
anatomic structures and activates the expression of HOXA9-
HOXA13 genes to promote distal limb development (Wang
et al., 2011). Characterization of these lncRNAs has often
occurred through overexpression or siRNA knockdown studies.
While these strategies often yield relevant results, transcriptional
modulation is often not complete, especially using siRNA (or
even short hairpin RNA), necessitating alternative methods.
Recently there have been a number of studies utilizing gene
KO to understand lncRNA biology (Grote et al., 2013; Li et al.,
2013; Sauvageau et al., 2013). At least three KO strategies
have been reported: (1) insertion of a polyA signal near the tran-
scription start sites; (2) insertion of a reporter gene under the
control of the endogenous promoter; and (3) complete deletion
of the lncRNA locus. The latter is the most dramatic and may,
in addition to removing the lncRNA exons/intron structure, re-
move unknown regulatory elements. Insertion of a reporter
gene has the advantage of being able to monitor expression of
the lncRNA throughout development; however, depending on
which sequences are replaced, it may also carry similar draw-
backs as the deletion strategy. Finally, insertion of a polyA signal
near the transcription start sites likely has the least off-target
effects; however, background expression from the lncRNA locus
could still result from not removing downstream sequences,
cryptic start sites, or inefficient polyA tailing and cleavage.
Elucidating lncRNA Tissue Patterning by KO Models
Recent efforts have begun to utilize full KO strategies to charac-
terize additional lncRNAs including Hox encoded candidates.The developmental functions of mouse Hotair were investigated
by full lncRNA locus deletion in themouse (Li et al., 2013). Loss of
Hotair resulted in aberrant patterning of the skeletal system dur-
ing development, as was evident in abnormalities in thewrist and
spine, including a switch of vertebral segment identity called
homeotic transformation. Further, genome-wide characteriza-
tion of the Hotair KO mouse confirmed that murine Hotair acted
similarly to human HOTAIR, namely as a trans-acting lncRNA
controlling histone modification at specific genomic loci (Li
et al., 2013). More recently, in an effort to dramatically expand
the number of lncRNA KOs, Rinn and colleagues used the re-
porter gene approach to generate 18 separate lncRNA knockout
mice (Sauvageau et al., 2013). By replacing lncRNA exonic re-
gions with a LacZ construct, both KO and tagging was achieved.
Three of the 18 lncRNAs (Fendrr, Peril, and Mdgt) showed vari-
able penetrance and lethality. The Mdgt and Pint KO lead to
abnormally low body weight and slower growth. The detailed
characterization of the lncRNA Brn1b revealed its role in cortical
development; specifically, this lncRNA was important for the
embryonic patterning in certain areas of projection neurons. By
creating a large number of lncRNA KO mice and characterizing
many of their functions in vivo, this study helped to solidify the
functional importance of lncRNAs. While thousands of lncRNAs
remain to be genetically tested, new and more facile genome-
editing tools should speed future characterization (Mali et al.,
2013).
Sauvageu et al. also generated a new Fendrr KO mouse (Sau-
vageau et al., 2013). Under these conditions, Fendrr was ex-
pressed much more widely than previously observed and most
highly in the developing lung. Fendrr KO resulted in perinatal
lethality, as Fendrr/ embryos either failed to initiate breathing
or stop breathing within 5 hr of birth, neither of which was
observed in wild-type pups. While the most striking phenotype
of this KO was pulmonary, heart septal defects were also
apparent even though their LacZ construct did not stain the heart
for expression. This discrepancy is an important example of the
possible phenotypic difference achieved by differential KO stra-
tegies such as reporter construct replacement or early polyA
termination (Grote et al., 2013; Sauvageau et al., 2013). Specif-
ically, addition of the polyA sites resulted in minimal disruption
of the endogenous Fendrr locus, but extremely low levels of
Fendrr were still detectable (Grote and Herrmann, 2013). On
the other hand, the LacZ construct replaced 20 kb of the
genome, resulting in a complete lack of Fendrr transcripts; how-
ever, this large replacement may have removed other functional
elements from the genome responsible for regulating other
genes. Therefore, while both approaches confirmed loss of the
lncRNA transcript, additional investigation is necessary and
careful consideration of the cellular outcomes from any partic-
ular targeting strategy must be included in the experimental
design.
Single-Cell Analysis of lncRNA Function
Most transcript-profiling experiments of lncRNAs have em-
ployed bulk measurements, reporting results from an average
of thousands or millions of cells. Recent work at the single-cell
level has revealed how much heterogeneity exists even within
a ‘‘clonal’’ population of cells (Buganim et al., 2012; Shalek
et al., 2013). Thus, it follows that examination of the noncoding
genome and its function at the single-cell level could also revealCell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc. 755
Figure 2. lncRNAs Program Active and
Silent Chromatin States
Top: in ESCs active chromatin is achieved and
maintained through multiple mechanisms. cis-
acting lncRNAs can recruit the MLL/WDR5 com-
plex to deposit H3K4me3 at promoters. Enhancer
regions can transcribe enhancer RNAs (eRNAs);
some enhancer-like RNAs bring Mediator to
promoters to contribute to gene activation. Addi-
tionally, through interactions with the nascent
transcribed RNA, canonical silencing factors such
as PRC2 and DNMT1 are titrated away from active
chromatin. Bottom: chromatin also employs many
lncRNA-based mechanisms to stay silent. Ezh2
and JARID2 (subunits of PRC2) may bind lncRNAs
to facilitate specific chromatin targeting or to
enhance PRC2 complex assembly and stability.
Additionally, when nascent RNA production is low,
DNMT1 can interact with the chromatin and act to
silence through DNA methylation.
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successfully elucidated the role lncRNAs present at a low copy
number (Wang et al., 2011), the accuracy of such reports re-
mains challenging when working with bulk populations.
Recent characterization of an lncRNA, named lincHOXA1,
located in the 30 end of the HoxA cluster by Raj and colleagues,
brought to light the importance of carefully examining, at the
single-cell level, the function of lowly expressed lncRNAs (Maa-
mar et al., 2013). Initial analysis, at the bulk cell level, ascribed a
positive correlation to the expression of lincHOXA1 and a nearby
mRNA HOXA1. Surprisingly, however, single-cell analysis re-
vealed an anticorrelation, and specifically a switch-like relation-
ship was observed such that if a cell had above ten copies of
lincHOXA1, HOXA1 was repressed. Knockdown studies used
both siRNA and antisense oligonucleotides (ASO, via RNase
H-mediated cleavage of the target RNA). The two depletion
methods differ in their capacity to reduce lincHOXA1 levels on
the chromatin versus total levels, with siRNA treatment unable
to efficiently lower chromatin-associated transcripts. Function-
ally, lincHOXA1 was found to partner with purine-rich element-
binding protein B (PURB) and exert transcriptional silencing of
HOXA1. Importantly, this study highlights two key and common756 Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc.methodological decision points: context
of cellular measurements and RNA
knockdown strategies. In this case, bulk
measurements would have masked
the anticorrelated relationship between
lincHOXA1 and HOXA1, which could
have led to key misinterpretations. Addi-
tionally, use of siRNAs, which was effec-
tive in reducing total cellular levels of
lincHOXA1, was not efficient at depleting
the functional lincHOXA1 transcripts.
Future work examining the molecular
roles of both coding and noncoding
transcripts should choose carefully the
methods and context in which experi-
ments are performed. As single-cell anal-
ysis and ASO technology become more
robust and widely adopted, it is likelythat many unknown features of known lncRNAs may be re-
vealed.
LncRNAs Regulation of Pluripotency
The richness of the lncRNA regulatory landscape is perhaps best
exemplified in ESCs, where the noncoding transcriptome has
been under intense study. The expansive number of genomic
data sets, both RNA- and chromatin-based, now available in
ESCs provides a rich database to characterize lncRNA function.
Recent progress in understanding lncRNA control of pluripo-
tency and dosage-compensation mechanisms have revealed
intimate connections between lncRNAs and chromatin state
(Figure 2). Some of the most studied lncRNA binding proteins
belong to chromatin modification complexes, including PRC2
and MLL, which act to suppress and activate, respectively, tran-
scription through methylation of histone protein.
Transition between Cell States
Characterization of the transcriptome of ESCs has revealed
many lncRNAs that participate in the regulation of the pluripotent
state (Guttman et al., 2011, 2009; Lin et al., 2014; Ng et al., 2012;
Sheik Mohamed et al., 2010). Through a comprehensive ‘‘per-
turb-and-measure’’ strategy, Guttman et al. showed that dozens
Cell Stem Cell
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terns of mouse ESCs or the first step of differentiation toward
different germ layers (Guttman et al., 2011). A subset of these
lncRNAs bound one or more chromatin modification complexes,
including readers, writers, or erasers of repressive histone
modifications.
In contrast, the ‘‘regulator of reprogramming’’ lncRNA
(lincRNA-RoR) was identified as an important factor for the re-
programming process as its depletion or overexpression leads
to a lower or higher efficiency of reprogramming fibroblasts to
iPSCs, respectively (Loewer et al., 2010). However only recently
was the molecular mechanism investigated (Wang et al., 2013).
Pull-down experiments with lincRNA-RoR specifically isolated
miR-145-5p, 181a-5p, and 99b-3p, as well as the miR-targeting
protein Argonaute2 (Ago2). These miRs have been previously
shown to regulate core pluripotency factors such as Pou5f1,
Sox2, and NANOG, suggesting that lincRNA-RoR might act as
a ceRNA. Indeed, functional assays revealed that lincRNA-RoR
regulated themature formofmiR-145, characteristic of a ceRNA.
Loss of lncRNA-RoR caused human ESCs (hESCs) to differen-
tiate toward mesoderm and ectoderm, while overexpression
conferred a differentiation defect. Additionally, in the context of
cancer, a rapidly proliferative state similar to ESCs, lincRNA-
RoR was recently shown to act in a regulatory loop suppressing
the expression of the tumor suppressor p53 (Zhang et al., 2013).
Together, this characterization of lincRNA-RoR further advances
the idea that each lncRNA may control many pathways in
different cellular contexts including tumor growth and core plu-
ripotency gene network utilizing a ceRNA mechanism.
Activation of the Epigenome with lncRNAs
To date, the vast majority of lncRNAs have annotated functions
in repressive complexes, with only a few examples of activating
or enhancing lncRNAs (Wang et al., 2011; Zhang et al., 2009).
HOTTIP, named due to its location at the distal ‘‘tip’’ of the
HOXA gene cluster, enforces an active chromatin state by re-
cruiting the WDR5 subunit of the MLL complex (Wang et al.,
2011) (Figure 2). The HOTTIP locus comes into spatial proximity
with its target genes, and all the while the expression level of
HOTTIP remains near one copy per cell (Wang et al., 2011).
The low copy number of HOTTIP ensures that HOTTIP acts pre-
cisely in cis on target genes defined by proximity in three-dimen-
sional nuclear space but not broadly on other genes. More
recently, biochemical characterization of the interaction be-
tween WDR5 and HOTTIP revealed a specific RNA-binding
pocket of WDR5 and that RNA binding could stabilize chro-
matin-associated WDR5 (Yang et al., 2014). This finding
suggested that in vivo, not only the localization, but also the
half-life of WDR5 could be modulated by HOTTIP. Given that
WDR5/MLL acts at many genomic loci, RNA immunoprecipita-
tion-seq (RIP-seq) was used to identify over 1,400 WDR5 inter-
acting RNAs, including many coding and noncoding RNAs. An
lncRNA-binding pocket on WDR5 was discovered, and a spe-
cific mutation of the RNA-binding pocket selectively abrogated
RNA binding but no other functions of the WDR5-MLL complex
(Yang et al., 2014). This selective WDR5 mutant revealed that
RNA binding is important for the temporal stability of the active
chromatin mark H3K4me3 over time and maintenance of ESC
pluripotency. These studies suggest a generalizable mechanism
for functional MLL/WDR5-RNA interaction. Specifically, HOTTIPacts in cis and is expressed at far too low levels per cell to
globally modulate the MLL/WDR5 chromatin localization. The
RIP-seq of WDR5 in mESCs (which do not express HOTTIP) re-
vealed that more than one thousand cellular RNAs could interact
with and may modulate the chromatin modification complex.
Because WDR5 targets over 10,000 genomic sites (Ang et al.,
2011), whether the three-dimensional organization of the
genome facilitates lncRNA coregulation of the mESC self-
renewal program remains to be addressed in future studies.
Epigenetic Repression through lncRNA-PRC2
Interactions
Unlike activating chromatin complexes, chromatin-modifying
complexes that repress transcription have been more exten-
sively studied in the context of lncRNA interactions, resulting in
a richer set of known interactions. The focus of many of these
studies has been the PRC2 complex, responsible for depositing
H3K27me3, which plays roles pluripotency, differentiation, XCI,
and diseases such as cancer (Margueron and Reinberg, 2011).
An initial survey of the RNA-interactome of Ezh2 yielded more
than 9,000 target RNAs using RIP-seq in mESCs (Zhao et al.,
2010). Recently, two studies have revisited this observation to
further clarify the interplay between RNA and PRC2 (Davidovich
et al., 2013; Kaneko et al., 2013) (Figure 2). Biochemical interac-
tion and photoactivated RNA-crosslinking experiments suggest
that Ezh2 can interact with numerous RNAs, including the 50 end
of nascent RNAs that are actively transcribed. The apparently
specific interactions of PRC2 with several lncRNAs in lysate
and in vivo are not recapitulated in vitro by the core PRC2 com-
plex alone. The promiscuous RNA binding of Ezh2 may be
modulated by additional proteins, such as Jarid2 and others,
to facilitate higher degrees of specificity in vivo (Davidovich
et al., 2013; see below). Moreover, Ezh2 may scan the genome
surveying the transcriptional status of its targets. Actively tran-
scribed regions may continually push Ezh2 away via their elon-
gating mRNAs, while silent regions or those stably bound by
lncRNAs (generated in trans) can be silenced. This proposed
mechanism reinforces the status quo of gene transcription and
silencing and is consistent with the known genetic role of
Polycomb group proteins in chromatin state maintenance.
A similar RNA surveillancemechanism is also employed by the
DNA methylase DNMT1 that interacts with many cellular tran-
scripts, including the nonpolyadenylated extracoding CEBPA
(ecCEBPA) lncRNA. The ecCEBPA lncRNA adopts a character-
istic stem-loop structure critical for interaction with DNMT1 and,
when transcribed, acts to shield the CEBPA locus from DNA
methylation (Di Ruscio et al., 2013) (Figure 2). These two exam-
ples provide evidence that cells employ RNAs to modulate the
deposition of repressive epigenetic marks in a genome-wide
manner. Nonetheless, recognition of the potentially broad
interactions between RNA and PRC2 highlights the need for
high-quality in vivo controls and validation of RNA-protein inter-
actions. Methodological choice is critical as each assay type has
its own strengths and weaknesses, which will impact the results
obtained and conclusions drawn.
While PCR2 operates in a wide range of cell types, certain sub-
units, such as JARID2, are specifically expressed and partner
with PCR2 in ESCs and certain dividing cells, including cancer
cells (Pasini et al., 2010; Peng et al., 2009; Shen et al., 2009).
These initial studies established JARID2’s capacity to regulateCell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc. 757
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(Figure 2). Further expanding the cellular functions of JARID2,
in vitro RNA-binding assays and in vivo PAR-CLIP suggest that
JARID2 directly interacts with cellular RNAs (Kaneko et al.,
2014). JARID2 and Ezh2 reproducibly crosslinked to 106 and
165 lncRNAs, respectively, and 53 lncRNAs were commonly
bound. The MEG3 lncRNA was bound by both subunits of
PRC2; however, the RNA-binding region (RBR) of JARID2 pro-
vided the largest contribution of MEG3 binding to PRC2. Addi-
tionally, cellular levels of MEG3 contribute to PRC2’s chromatin
association, as low expression of MEG3 resulted in the loss of
PRC2 subunits from specific loci leading to derepression of the
nearby genes. Finally, the in vitro interaction between JARID2
and Ezh2 was facilitated by HOTAIR and MEG3, and Ezh2’s
chromatin association was shown to be partially dependent on
JARID2’s RNA-binding domain. Thus, JARID2, an ESC-specific
subunit of PRC2, appears to modulate the localization of
PRC2, and thus the chromatin state, in an RNA-dependent
manner. While this study offers an additional layer of regulation
with respect to the Polycomb complex, little is known about
the other RNA targets of JARID2, which may significantly
contribute to its cellular function. Additionally, studies to rigor-
ously interrogate the enzymatic properties of the PRC2 complex
inside cells with and without its RNA partners will be very
informative.
An lncRNA Network to Control Dosage Compensation
Dosage compensation of genes encoded on the X chromosome
is accomplished by divergent strategies in different species;
however, the use of lncRNAs is a common feature. InDrosophila,
dosage compensation is achieved by precisely upgregulating
the X chromosome in males by 2-fold (Lucchesi et al., 2005). A
desire to understand howdosage compensation operates fueled
the development of ChIRP and CHART, genomic tools that map
the chromatin association of lncRNAs (Chu et al., 2011; Simon
et al., 2011). Initially, ChIRP and CHART were applied to the
Drosophila roX2 lncRNA, which provided evidence that roX2
co-occupies genomic loci with the known dosage compensation
protein factors on the X chromosome. Importantly, they proved
that mapping the genomic locations of lncRNAs can generate
novel hypotheses for functions of lncRNAs. While studies in
Drosophila and other model systems have provided key insights
into mechanisms of dosage compensation, we will focus on
recent investigations conducted in mammalian cells.
Xist Spreading
In mammals, the strategy for dosage compensation is reverse
fromDrosophila: female cells selectively repress one entire chro-
mosome by upregulating the repressive lncRNA Xist (Lee, 2012).
Xist is transcribed from the X-inactivation center (XIC) and is
responsible for physically coating and silencing the X chromo-
some targeted for the Barr body (the Inactive X, Xi). Another
lncRNA, Tsix, is transcribed from the active X chromosome (Xa)
and enforces silencing of Xist (Lee, 2012). These two lncRNAs,
together with others described below, form a complex RNA-pro-
tein regulatory network that controls X chromosome dosage
compensation in mammals.
Traditional techniques such as immunofluorescence (IF) and
RNA fluorescence in situ hybridization (FISH) have been widely
applied to study X chromosome inactivation (XCI) and have758 Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc.arrived at a consensus mechanism: elevated Xist expression
from the future Xi leads to a cloud-like coating of Xist on Xi and
finally epigenetic silencing and chromatin compaction. While
informative, IF and RNA-FISH studies had resolution limitations,
and as was true for the roX2 RNA, specifically mapping the
genomic locations of Xist held the promise of answering mecha-
nistic features of its function. Recently, application of CHART
and the development and application of RAP (a method with
similar principles as ChIRP and CHART) to the Xist lncRNA
defined its precise chromatin association (Engreitz et al., 2013;
Simon et al., 2013). Together, the studies revealed that the initi-
ation of Xist spreading occurs from the Xist locus to distinct sites
across the X chromosome that are not directly adjacent to its
locus. These regions are highly accessible by DNaseI footprint-
ing and contain many genes that are actively transcribed prior
to silencing. Once Xist is deposited on these early sites, it pro-
ceeds to spread and coat the rest of the chromosome to fully
silence all but a few genes that escape XCI. It is proposed that
the initial deposition process is mediated through higher-order
chromatin architecture (Engreitz et al., 2013); however, experi-
mental design differences between the two studies described
above make it difficult to directly compare the chromatin confor-
mation results measured. While further investigation is clearly
needed to solidify and refine these results, using high-resolution
genomic tools (ChIRP, CHART, or RAP) can provide critical
insight into lncRNA-controlled systems previously hidden from
view.
Mechanisms of Xist Regulation
Intense study of the Xist regulatory network has uncoveredmany
novel lncRNAs in and around the XIC, often illuminating novel
mechanistic concepts for how lncRNAs function. Within the
lncRNA network that controls Xist, Tsix and Jpx oppose each
other’s function by repressing or activating, respectively, the
transcription of Xist (Lee, 2000; Tian et al., 2010). Recently, addi-
tional characterization of the Jpx pathway revealed an unex-
pected interplay between the lncRNA Jpx and CCCTC-binding
factor (CTCF), a major DNA-binding protein involved in higher-
order chromosomal folding and interactions (Sun et al., 2013).
During female mESC differentiation, CTCF is lost from the Xist
locus, therefore allowing allele-specific Xist upregulation. Molec-
ular characterization of this regulatory loop revealed that CTCF
directly binds Jpx and this interaction can titrate CTCF from its
DNA targets. Within the conceptual framework of dosage
compensation, this puts Jpx and CTCF as central players in
the balance between activation and silencing of the X chromo-
some. Cellular levels of Jpx, as partially determined by the num-
ber of X chromosomes, would control the ability of CTCF to bind
and inhibit transcription at the Xist locus only under conditions
when XCI is required. Another recent study more globally char-
acterized the RNA-binding capacity of CTCF and found a multi-
tude of RNA targets, including Wrap53, an lncRNA that controls
the induction of the tumor suppressor p53 upon DNA damage
(Saldan˜a-Meyer et al., 2014). Interestingly, biochemical charac-
terization of CTCF’s protein domains revealed that the RBR
and RNA promoted multimerization of CTCF.
While Xist is modulated by CTCF localization and the spatio-
temporal deposition of Xist has been initially defined through
CHART and RAP, how Xist interacts with protein effectors of
XCI remains poorly understood. The repeat A (RepA) domain of
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Figure 3. lncRNAs Mark ESC State and Reprogramming Success
X chromosome inactivation (XCI) is a key step in the commitment of ESCs to
differentiated cell types. The network on lncRNAs, signaling pathways, and
protein effectors that control XCI are depicted. These features can distinguish
the stemness of different ESC states and iPSC quality.
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complex (Zhao et al., 2008). Recent characterization of the
JARID2 subunit of PRC2 also implicates it in functionally inter-
acting with Xist (da Rocha et al., 2014). Specifically, the authors
observed JARID2 and other PCR2 subunits co-occupying
genomic regions on the Xi, and a requirement for JARID2 for
the deposition of H3K27me3. Further, Xist deletion experiments
defined the RepB and RepF regions within the RNA as respon-
sible for JARID2 targeting to the Xi. Interestingly, this function
was not depended on its previously identified RBR (Kaneko
et al., 2014), suggesting that JARID2 is a multifunctioning RNA-
binding protein that mediates the association of PRC2 to the Xi
through Xist. These examples suggest that within the context
of XCI, as well as during other critical cellular decisions, lncRNAs
(such as Xist) can act to modulate chromosome architecture and
chromatin modification patterns.
XCI as a Marker of Reprogramming
The ability to transform differentiated cells back into pluripotent
cells holds tremendous possibilities for regenerative medicine,
but many hurdles still remain before this technology is fully
matured (Sa´nchez Alvarado and Yamanaka, 2014). Because
biallelic X activation is a key epigenetic marker of pluripotency,
the status of Xist and Xist-mediated gene silencing (or lack
thereof) can be exploited to phenotype ESCs and iPSCs
(Figure 3). Careful analysis of human iPSCs derived from female
cells revealed that many carried an Xi, failing to undergo X chro-
mosome reactivation (XCR), and are epigenetically dynamic,
suggesting that the derivation of hiPSCs may not result in
pristinely pluripotent cells as desired (Tchieu et al., 2010). A sub-
sequent study used X-inactivation markers to segregate popula-
tions of hiPSCs and found that female-derived iPSCs are likely to
be less stable in culture than male-derived cells (Anguera et al.,
2012). Indeed, erosion of dosage compensation has been
observed in female hiPSCs over time in culture, significantly
impacting the potential use of these cells for modeling X-linked
disease (Mekhoubad et al., 2012). More recent work character-
ized XCR in the context of iPSC reprogramming and found
PRDM14, involved in the ESC pluripotency network, controls
Xist silencing (Payer et al., 2013). With the help of Tsix,
PRDM14 represses Xist activators (Rnf12 and Jpx) and the Xistlocus itself by recruiting PRC2, placing PRDM14 expression as
a marker for XCR. Work from Heard and colleagues also
explored how Xist status can directly regulate ESC differentia-
tion, notably within the framework of the primed/metastable
and ground/naive states, with the latter representing a more
primordial state of pluripotency. Schultz et al. reported that an
X-linked inhibitor ofMAPK signaling couples the status of X chro-
mosomes to ESC differentiation. In the ground state where both
X chromosomes are active, MAPK is inhibited concomitantly
with other molecular changes that block ESC differentiation
(Schulz et al., 2014). Upon X chromosome inactivation in the
primed state, the relief of MAPK inhibition leads to high MAPK
signaling and the capacity to proceed with differentiation. There-
fore the characteristic expression of Xist and X-silencing genes
provides new ways to evaluate the efficiency and ultimately con-
trol of reprograming during iPSC generation. Combining tradi-
tional pluripotency markers with new markers like X-inactivation
will be critical to achieve the standardization and consistency
necessary for clinical application of iPSC technologies.
Lessons and Future Prospects
While the myriad examples to date highlight the functions of a
small fraction of known lncRNAs, they illustrate the principle
that lncRNAs are intimately involved in the specification, self-
renewal, differentiation, and patterning of stem cells and their
differentiated progenies. It is reasonable to anticipate that similar
principles will be uncovered in many additional organ systems
and cell types. A frequently asked question is ‘‘Why RNA’’?
lncRNAs exhibit exquisite cell-type- and organ-specific expres-
sion patterns, in fact, to a greater extent than mRNAs. Evolution
has probably taken advantage of this fertile soil of cell-type- and
state-specific transcription to evolve regulatory functions. Thus,
one area of future investigation should focus on the regulation of
lncRNA expression—what exactly makes them different and
endows them with such state-specific expression? A second
challenge for the field is the need to predict the functions of
lncRNAs from primary sequence. Finally, understanding how
the structure of lncRNAs guides their function remains largely
unexplored. As has been true for protein biochemistry, under-
standing the physical conformations lncRNAs adopt inside cells
will undoubtedly uncover novel functional domains and struc-
tural elements responsible for their cellular activities.
ACKNOWLEDGMENTS
We apologize to colleagues whose work was not discussed due to space
constraints. We thankM.Wernig, E. Heard, R.C. Spitale, A.J. Rubin, andmem-
bers of the H.Y.C. lab for comments. This work was supported by NIH Medical
Scientist Training Program (R.A.F.) and NIH (RO1-CA118750, RO1-ES023168)
and California Institute for Regenerative Medicine (H.Y.C.). H.Y.C. is an Early
Career Scientist of the Howard Hughes Medical Institute.
REFERENCES
Ang, Y.-S., Tsai, S.-Y., Lee, D.-F., Monk, J., Su, J., Ratnakumar, K., Ding, J.,
Ge, Y., Darr, H., Chang, B., et al. (2011). Wdr5 mediates self-renewal and re-
programming via the embryonic stem cell core transcriptional network. Cell
145, 183–197.
Anguera, M.C., Sadreyev, R., Zhang, Z., Szanto, A., Payer, B., Sheridan, S.D.,
Kwok, S., Haggarty, S.J., Sur, M., Alvarez, J., et al. (2012). Molecular signa-
tures of human induced pluripotent stem cells highlight sex differences and
cancer genes. Cell Stem Cell 11, 75–90.Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc. 759
Cell Stem Cell
ReviewBatista, P.J., and Chang, H.Y. (2013). Long noncoding RNAs: cellular address
codes in development and disease. Cell 152, 1298–1307.
Berghoff, E.G., Clark, M.F., Chen, S., Cajigas, I., Leib, D.E., and Kohtz, J.D.
(2013). Evf2 (Dlx6as) lncRNA regulates ultraconserved enhancer methylation
and the differential transcriptional control of adjacent genes. Development
140, 4407–4416.
Bertani, S., Sauer, S., Bolotin, E., and Sauer, F. (2011). The noncoding RNA
Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation
by recruiting MLL1 to chromatin. Mol. Cell 43, 1040–1046.
Bond, A.M., Vangompel, M.J.W., Sametsky, E.A., Clark, M.F., Savage, J.C.,
Disterhoft, J.F., and Kohtz, J.D. (2009). Balanced gene regulation by an
embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat.
Neurosci. 12, 1020–1027.
Bosia, C., Pagnani, A., and Zecchina, R. (2013). Modelling competing endog-
enous RNA networks. PLoS ONE 8, e66609.
Buganim, Y., Faddah, D.A., Cheng, A.W., Itskovich, E., Markoulaki, S., Ganz,
K., Klemm, S.L., van Oudenaarden, A., and Jaenisch, R. (2012). Single-cell
expression analyses during cellular reprogramming reveal an early stochastic
and a late hierarchic phase. Cell 150, 1209–1222.
Burridge, P.W., Keller, G., Gold, J.D., and Wu, J.C. (2012). Production of
de novo cardiomyocytes: human pluripotent stem cell differentiation and
direct reprogramming. Cell Stem Cell 10, 16–28.
Cabili, M.N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., and
Rinn, J.L. (2011). Integrative annotation of human large intergenic noncoding
RNAs reveals global properties and specific subclasses. Genes Dev. 25,
1915–1927.
Cesana,M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O., Chinappi, M.,
Tramontano, A., and Bozzoni, I. (2011). A long noncoding RNA controls muscle
differentiation by functioning as a competing endogenous RNA. Cell 147,
358–369.
Chu, C., Qu, K., Zhong, F.L., Artandi, S.E., and Chang, H.Y. (2011). Genomic
maps of long noncoding RNA occupancy reveal principles of RNA-chromatin
interactions. Mol. Cell 44, 667–678.
da Rocha, S.T., Boeva, V., Escamilla-Del-Arenal, M., Ancelin, K., Granier, C.,
Matias, N.R., Sanulli, S., Chow, J., Schulz, E., Picard, C., et al. (2014). Jarid2
is implicated in the initial Xist-induced targeting of PRC2 to the inactive X chro-
mosome. Mol. Cell 53, 301–316.
Davidovich, C., Zheng, L., Goodrich, K.J., and Cech, T.R. (2013). Promiscuous
RNA binding by Polycomb repressive complex 2. Nat. Struct. Mol. Biol. 20,
1250–1257.
Deng, Z., Cao, P., Wan, M.M., and Sui, G. (2010). Yin Yang 1: a multifaceted
protein beyond a transcription factor. Transcription 1, 81–84.
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guer-
nec, G., Martin, D., Merkel, A., Knowles, D.G., et al. (2012). The GENCODE v7
catalog of human long noncoding RNAs: analysis of their gene structure, evo-
lution, and expression. Genome Res. 22, 1775–1789.
Di Ruscio, A., Ebralidze, A.K., Benoukraf, T., Amabile, G., Goff, L.A., Terragni,
J., Figueroa, M.E., De Figueiredo Pontes, L.L., Alberich-Jorda, M., Zhang, P.,
et al. (2013). DNMT1-interacting RNAs block gene-specific DNA methylation.
Nature 503, 371–376.
Engreitz, J.M., Pandya-Jones, A., McDonel, P., Shishkin, A., Sirokman, K.,
Surka, C., Kadri, S., Xing, J., Goren, A., Lander, E.S., et al. (2013). The Xist
lncRNA exploits three-dimensional genome architecture to spread across
the X chromosome. Science 341, 1237973.
Grote, P., and Herrmann, B.G. (2013). The long non-coding RNA Fendrr links
epigenetic control mechanisms to gene regulatory networks in mammalian
embryogenesis. RNA Biol. Published online August 22, 2013. http://dx.doi.
org/10.4161/rna.26165.
Grote, P., Wittler, L., Hendrix, D., Koch, F., Wa¨hrisch, S., Beisaw, A., Macura,
K., Bla¨ss, G., Kellis, M., Werber, M., and Herrmann, B.G. (2013). The tissue-
specific lncRNA Fendrr is an essential regulator of heart and body wall devel-
opment in the mouse. Dev. Cell 24, 206–214.
Guttman, M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M.,
Zuk, O., Carey, B.W., Cassady, J.P., et al. (2009). Chromatin signature reveals760 Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc.over a thousand highly conserved large non-coding RNAs in mammals. Nature
458, 223–227.
Guttman, M., Donaghey, J., Carey, B.W., Garber, M., Grenier, J.K., Munson,
G., Young, G., Lucas, A.B., Ach, R., Bruhn, L., et al. (2011). lincRNAs act in
the circuitry controlling pluripotency and differentiation. Nature 477, 295–300.
Kaneko, S., Son, J., Shen, S.S., Reinberg, D., and Bonasio, R. (2013). PRC2
binds active promoters and contacts nascent RNAs in embryonic stem cells.
Nat. Struct. Mol. Biol. 20, 1258–1264.
Kaneko, S., Bonasio, R., Saldan˜a-Meyer, R., Yoshida, T., Son, J., Nishino, K.,
Umezawa, A., and Reinberg, D. (2014). Interactions between JARID2 and non-
coding RNAs regulate PRC2 recruitment to chromatin. Mol. Cell 53, 290–300.
Klattenhoff, C.A., Scheuermann, J.C., Surface, L.E., Bradley, R.K., Fields, P.A.,
Steinhauser, M.L., Ding, H., Butty, V.L., Torrey, L., Haas, S., et al. (2013).
Braveheart, a long noncoding RNA required for cardiovascular lineage
commitment. Cell 152, 570–583.
Kretz, M., Webster, D.E., Flockhart, R.J., Lee, C.S., Zehnder, A., Lopez-
Pajares, V., Qu, K., Zheng, G.X.Y., Chow, J., Kim, G.E., et al. (2012). Suppres-
sion of progenitor differentiation requires the long noncoding RNA ANCR.
Genes Dev. 26, 338–343.
Kretz, M., Siprashvili, Z., Chu, C.,Webster, D.E., Zehnder, A., Qu, K., Lee, C.S.,
Flockhart, R.J., Groff, A.F., Chow, J., et al. (2013). Control of somatic tissue dif-
ferentiation by the long non-coding RNA TINCR. Nature 493, 231–235.
Lee, J.T. (2000). Disruption of imprinted X inactivation by parent-of-origin
effects at Tsix. Cell 103, 17–27.
Lee, J.T. (2012). Epigenetic regulation by long noncoding RNAs. Science 338,
1435–1439.
Legnini, I., Morlando, M., Mangiavacchi, A., Fatica, A., and Bozzoni, I. (2014). A
feedforward regulatory loop between HuR and the long noncoding RNA linc-
MD1 controls early phases of myogenesis. Mol. Cell 53, 506–514.
Li, L., Liu, B., Wapinski, O.L., Tsai, M.-C., Qu, K., Zhang, J., Carlson, J.C., Lin,
M., Fang, F., Gupta, R.A., et al. (2013). Targeted disruption of Hotair leads to
homeotic transformation and gene derepression. Cell Rep. 5, 3–12.
Lin, N., Chang, K.-Y., Li, Z., Gates, K., Rana, Z.A., Dang, J., Zhang, D., Han, T.,
Yang, C.-S., Cunningham, T.J., et al. (2014). An evolutionarily conserved long
noncoding RNA TUNA controls pluripotency and neural lineage commitment.
Mol. Cell 53, 1005–1019.
Loewer, S., Cabili, M.N., Guttman, M., Loh, Y.-H., Thomas, K., Park, I.H.,
Garber, M., Curran, M., Onder, T., Agarwal, S., et al. (2010). Large intergenic
non-coding RNA-RoR modulates reprogramming of human induced pluripo-
tent stem cells. Nat. Genet. 42, 1113–1117.
Lu, L., Zhou, L., Chen, E.Z., Sun, K., Jiang, P., Wang, L., Su, X., Sun, H., and
Wang, H. (2012). A novel YY1-miR-1 regulatory circuit in skeletal myogenesis
revealed by genome-wide prediction of YY1-miRNA network. PLoS ONE 7,
e27596.
Lu, L., Sun, K., Chen, X., Zhao, Y., Wang, L., Zhou, L., Sun, H., and Wang, H.
(2013). Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs
in skeletal myogenesis. EMBO J. 32, 2575–2588.
Lucchesi, J.C., Kelly, W.G., and Panning, B. (2005). Chromatin remodeling in
dosage compensation. Annu. Rev. Genet. 39, 615–651.
Maamar, H., Cabili, M.N., Rinn, J., and Raj, A. (2013). linc-HOXA1 is a noncod-
ing RNA that represses Hoxa1 transcription in cis. Genes Dev. 27, 1260–1271.
Mali, P., Esvelt, K.M., and Church, G.M. (2013). Cas9 as a versatile tool for
engineering biology. Nat. Methods 10, 957–963.
Margueron, R., and Reinberg, D. (2011). The Polycomb complex PRC2 and its
mark in life. Nature 469, 343–349.
Mehler, M.F., and Mattick, J.S. (2007). Noncoding RNAs and RNA editing
in brain development, functional diversification, and neurological disease.
Physiol. Rev. 87, 799–823.
Mekhoubad, S., Bock, C., de Boer, A.S., Kiskinis, E., Meissner, A., and Eggan,
K. (2012). Erosion of dosage compensation impacts human iPSC disease
modeling. Cell Stem Cell 10, 595–609.
Cell Stem Cell
ReviewMercer, T.R., Dinger, M.E., Mariani, J., Kosik, K.S., Mehler, M.F., and Mattick,
J.S. (2008). Noncoding RNAs in Long-Term Memory Formation. Neuroscien-
tist 14, 434–445.
Mercer, T.R., Gerhardt, D.J., Dinger, M.E., Crawford, J., Trapnell, C., Jedde-
loh, J.A., Mattick, J.S., and Rinn, J.L. (2012). Targeted RNA sequencing re-
veals the deep complexity of the human transcriptome. Nat. Biotechnol. 30,
99–104.
Mukherji, S., Ebert, M.S., Zheng, G.X.Y., Tsang, J.S., Sharp, P.A., and van
Oudenaarden, A. (2011). MicroRNAs can generate thresholds in target gene
expression. Nat. Genet. 43, 854–859.
Ng, S.-Y., Johnson, R., and Stanton, L.W. (2012). Human long non-coding
RNAs promote pluripotency and neuronal differentiation by association with
chromatin modifiers and transcription factors. EMBO J. 31, 522–533.
Onoguchi, M., Hirabayashi, Y., Koseki, H., and Gotoh, Y. (2012). A noncoding
RNA regulates the neurogenin1 gene locus during mouse neocortical develop-
ment. Proc. Natl. Acad. Sci. USA 109, 16939–16944.
Pasini, D., Cloos, P.A.C., Walfridsson, J., Olsson, L., Bukowski, J.-P., Johan-
sen, J.V., Bak, M., Tommerup, N., Rappsilber, J., and Helin, K. (2010). JARID2
regulates binding of the Polycomb repressive complex 2 to target genes in ES
cells. Nature 464, 306–310.
Payer, B., Rosenberg, M., Yamaji, M., Yabuta, Y., Koyanagi-Aoi, M., Hayashi,
K., Yamanaka, S., Saitou, M., and Lee, J.T. (2013). Tsix RNA and the germline
factor, PRDM14, link X reactivation and stem cell reprogramming.Mol. Cell 52,
805–818.
Peng, J.C., Valouev, A., Swigut, T., Zhang, J., Zhao, Y., Sidow, A., and
Wysocka, J. (2009). Jarid2/Jumonji coordinates control of PRC2 enzymatic
activity and target gene occupancy in pluripotent cells. Cell 139, 1290–1302.
Ramos, A.D., Diaz, A., Nellore, A., Delgado, R.N., Park, K.-Y., Gonzales-
Roybal, G., Oldham, M.C., Song, J.S., and Lim, D.A. (2013). Integration of
genome-wide approaches identifies lncRNAs of adult neural stem cells and
their progeny in vivo. Cell Stem Cell 12, 616–628.
Rapicavoli, N.A., Poth, E.M., Zhu, H., and Blackshaw, S. (2011). The long non-
coding RNA Six3OS acts in trans to regulate retinal development by modu-
lating Six3 activity. Neural Dev. 6, 32.
Rinn, J.L., and Chang, H.Y. (2012). Genome regulation by long noncoding
RNAs. Annu. Rev. Biochem. 81, 145–166.
Rinn, J.L., Kertesz, M., Wang, J.K., Squazzo, S.L., Xu, X., Brugmann, S.A.,
Goodnough, L.H., Helms, J.A., Farnham, P.J., Segal, E., and Chang, H.Y.
(2007). Functional demarcation of active and silent chromatin domains in
human HOX loci by noncoding RNAs. Cell 129, 1311–1323.
Saldan˜a-Meyer, R., Gonza´lez-Buendı´a, E., Guerrero, G., Narendra, V., Bona-
sio, R., Recillas-Targa, F., and Reinberg, D. (2014). CTCF regulates the human
p53 gene through direct interaction with its natural antisense transcript,
Wrap53. Genes Dev. 28, 723–734.
Sa´nchez Alvarado, A., and Yamanaka, S. (2014). Rethinking differentiation:
stem cells, regeneration, and plasticity. Cell 157, 110–119.
Sauvageau, M., Goff, L.A., Lodato, S., Bonev, B., Groff, A.F., Gerhardinger, C.,
Sanchez-Gomez, D.B., Hacisuleyman, E., Li, E., Spence, M., et al. (2013). Mul-
tiple knockout mouse models reveal lincRNAs are required for life and brain
development. Elife 2, e01749.
Schulz, E.G., Meisig, J., Nakamura, T., Okamoto, I., Sieber, A., Picard, C., Bor-
ensztein, M., Saitou, M., Blu¨thgen, N., and Heard, E. (2014). The two active
X chromosomes in female ESCs block exit from the pluripotent state by modu-
lating the ESC signaling network. Cell Stem Cell 14, 203–216.
Sen, G.L., Reuter, J.A., Webster, D.E., Zhu, L., and Khavari, P.A. (2010).
DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature
463, 563–567.
Shalek, A.K., Satija, R., Adiconis, X., Gertner, R.S., Gaublomme, J.T., Ray-
chowdhury, R., Schwartz, S., Yosef, N., Malboeuf, C., Lu, D., et al. (2013).
Single-cell transcriptomics reveals bimodality in expression and splicing in
immune cells. Nature 498, 236–240.Sheik Mohamed, J., Gaughwin, P.M., Lim, B., Robson, P., and Lipovich, L.
(2010). Conserved long noncoding RNAs transcriptionally regulated by Oct4
and Nanog modulate pluripotency in mouse embryonic stem cells. RNA 16,
324–337.
Shen, X., Kim, W., Fujiwara, Y., Simon, M.D., Liu, Y., Mysliwiec, M.R., Yuan,
G.-C., Lee, Y., and Orkin, S.H. (2009). Jumonji modulates polycomb activity
and self-renewal versus differentiation of stem cells. Cell 139, 1303–1314.
Simon, M.D., Wang, C.I., Kharchenko, P.V., West, J.A., Chapman, B.A., Alek-
seyenko, A.A., Borowsky, M.L., Kuroda, M.I., and Kingston, R.E. (2011). The
genomic binding sites of a noncoding RNA. Proc. Natl. Acad. Sci. USA 108,
20497–20502.
Simon, M.D., Pinter, S.F., Fang, R., Sarma, K., Rutenberg-Schoenberg, M.,
Bowman, S.K., Kesner, B.A., Maier, V.K., Kingston, R.E., and Lee, J.T.
(2013). High-resolution Xist binding maps reveal two-step spreading during
X-chromosome inactivation. Nature 504, 465–469.
Sun, S., Del Rosario, B.C., Szanto, A., Ogawa, Y., Jeon, Y., and Lee, J.T.
(2013). Jpx RNA activates Xist by evicting CTCF. Cell 153, 1537–1551.
Tay, Y., Rinn, J., and Pandolfi, P.P. (2014). The multilayered complexity of
ceRNA crosstalk and competition. Nature 505, 344–352.
Tchieu, J., Kuoy, E., Chin, M.H., Trinh, H., Patterson, M., Sherman, S.P.,
Aimiuwu, O., Lindgren, A., Hakimian, S., Zack, J.A., et al. (2010). Female hu-
man iPSCs retain an inactive X chromosome. Cell Stem Cell 7, 329–342.
Tian, D., Sun, S., and Lee, J.T. (2010). The long noncoding RNA, Jpx, is a
molecular switch for X chromosome inactivation. Cell 143, 390–403.
Truong, A.B., Kretz, M., Ridky, T.W., Kimmel, R., and Khavari, P.A. (2006). p63
regulates proliferation and differentiation of developmentally mature keratino-
cytes. Genes Dev. 20, 3185–3197.
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J.K., Lan, F., Shi,
Y., Segal, E., and Chang, H.Y. (2010). Long noncoding RNA as modular scaf-
fold of histone modification complexes. Science 329, 689–693.
Ulitsky, I., Shkumatava, A., Jan, C.H., Sive, H., and Bartel, D.P. (2011).
Conserved function of lincRNAs in vertebrate embryonic development despite
rapid sequence evolution. Cell 147, 1537–1550.
Wang, K.C., and Chang, H.Y. (2011). Molecular mechanisms of long noncod-
ing RNAs. Mol. Cell 43, 904–914.
Wang, K.C., Yang, Y.W., Liu, B., Sanyal, A., Corces-Zimmerman, R., Chen, Y.,
Lajoie, B.R., Protacio, A., Flynn, R.A., Gupta, R.A., et al. (2011). A long noncod-
ing RNA maintains active chromatin to coordinate homeotic gene expression.
Nature 472, 120–124.
Wang, Y., Xu, Z., Jiang, J., Xu, C., Kang, J., Xiao, L., Wu, M., Xiong, J., Guo, X.,
and Liu, H. (2013). Endogenous miRNA sponge lincRNA-RoR regulates Oct4,
Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev. Cell 25,
69–80.
Yang, Y.W., Flynn, R.A., Chen, Y., Qu, K., Wan, B., Wang, K.C., Lei, M., and
Chang, H.Y. (2014). Essential role of lncRNA binding for WDR5 maintenance
of active chromatin and embryonic stem cell pluripotency. Elife 3, e02046.
Zhang, X., Lian, Z., Padden, C., Gerstein, M.B., Rozowsky, J., Snyder, M., Gin-
geras, T.R., Kapranov, P., Weissman, S.M., and Newburger, P.E. (2009). A
myelopoiesis-associated regulatory intergenic noncoding RNA transcript
within the human HOXA cluster. Blood 113, 2526–2534.
Zhang, A., Zhou, N., Huang, J., Liu, Q., Fukuda, K., Ma, D., Lu, Z., Bai, C.,
Watabe, K., and Mo, Y.-Y. (2013). The human long non-coding RNA-RoR is
a p53 repressor in response to DNA damage. Cell Res. 23, 340–350.
Zhao, J., Sun, B.K., Erwin, J.A., Song, J.J., and Lee, J.T. (2008). Polycomb pro-
teins targeted by a short repeat RNA to the mouse X chromosome. Science
322, 750–756.
Zhao, J., Ohsumi, T.K., Kung, J.T., Ogawa, Y., Grau, D.J., Sarma, K., Song,
J.J., Kingston, R.E., Borowsky, M., and Lee, J.T. (2010). Genome-wide identi-
fication of polycomb-associated RNAs by RIP-seq. Mol. Cell 40, 939–953.Cell Stem Cell 14, June 5, 2014 ª2014 Elsevier Inc. 761
